A5038734496- Helicobacter pylori-related gastroenterology studies
- Infectious Diseases and Tuberculosis
- Gastric Cancer Management and Outcomes
- Orthopedic Infections and Treatments
- Hematological disorders and diagnostics
- Tuberculosis Research and Epidemiology
- Legionella and Acanthamoeba research
- HIV/AIDS Research and Interventions
- Eosinophilic Esophagitis
- HIV Research and Treatment
- Vector-borne infectious diseases
- Pharmaceutical studies and practices
- Reconstructive Facial Surgery Techniques
- Monoclonal and Polyclonal Antibodies Research
- Dermatological diseases and infestations
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV/AIDS drug development and treatment
- Viral Infections and Vectors
- Gastroesophageal reflux and treatments
- Nosocomial Infections in ICU
- Diagnosis and treatment of tuberculosis
- Cancer and Skin Lesions
- Infectious Aortic and Vascular Conditions
- Musculoskeletal Disorders and Rehabilitation
- Brucella: diagnosis, epidemiology, treatment
Hospital Clínico Universitario Lozano Blesa
2023-2024
Instituto de Investigación Sanitaria Aragón
2023-2024
Universidad de Zaragoza
2024
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
2024
Complejo Hospitalario Universitario de Albacete
2007-2018
Hospital General Universitario de Albacete
1998-2006
Bismuth quadruple therapies (BQTs) including bismuth, a proton pump inhibitor (PPI) and two antibiotics have been shown to be highly effective for treating
ABSTRACT Background The influence of indications for Helicobacter pylori investigation on prescriptions and effectiveness is unknown. aim the study was to assess impact H. prescriptions, effectiveness, compliance, tolerance. Methods International, prospective, non‐interventional registry management infection by European gastroenterologists (Hp‐EuReg). Treatment‐näive patients registered from 2013 2023 at e‐CRF AEG‐REDCap were analyzed. assessed modified intention‐to‐treat analysis. Results...